[1]
2024. EFFECT OF DAPAGLIFLOZIN, SITAGLIPTIN AND METFORMIN COMBINATION ON SOME METABLIC RISK FACTORS IN IRAQI PATIENTS WITH TYPE-2 DIABETES MELLITUS. Neuropsychopharmacologia Hungarica. 22, 1 (Jan. 2024), 204–209.